Search

Andreas Gosberg Phones & Addresses

  • 6492 Braemar Ave S, Noblesville, IN 46062 (317) 379-8025
  • 1702 Thorley Way, San Marcos, CA 92078
  • San Diego, CA

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Publications

Us Patents

Fused Ring Heterocycle Kinase Modulators

View page
US Patent:
7452993, Nov 18, 2008
Filed:
Jul 27, 2005
Appl. No.:
11/192318
Inventors:
William D. Arnold - San Diego CA, US
Andreas Gosberg - San Marcos CA, US
Zhe Li - San Diego CA, US
Ruo W. Steensma - La Jolla CA, US
Mark E. Wilson - Ramona CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 471/02
C07D 491/02
C07D 498/02
C07D 513/02
C07D 515/02
US Classification:
546119
Abstract:
The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.

Pyrrolo-Pyridine Kinase Modulators

View page
US Patent:
7582637, Sep 1, 2009
Filed:
Feb 29, 2008
Appl. No.:
12/040527
Inventors:
William D. Arnold - San Diego CA, US
Pierre-Yves Bounaud - San Diego CA, US
Andreas Gosberg - San Diego CA, US
Zhe Li Bounaud - San Diego CA, US
Ian McDonald - San Diego CA, US
Ruo W. Steensma - San Diego CA, US
Mark E. Wilson - San Diego CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/497
A61K 31/44
US Classification:
51425304, 514300
Abstract:
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.

Pyrrolo-Pyridine Kinase Modulators

View page
US Patent:
7601839, Oct 13, 2009
Filed:
Feb 29, 2008
Appl. No.:
12/040536
Inventors:
William D. Arnold - San Diego CA, US
Pierre-Yves Bounaud - San Diego CA, US
Andreas Gosberg - San Diego CA, US
Zhe Li Bounaud - San Diego CA, US
Ian McDonald - San Diego CA, US
Ruo W. Steensma - San Diego CA, US
Mark E. Wilson - San Diego CA, US
Assignee:
SGX Pharmaceuticals Inc. - San Diego CA
International Classification:
C07D 471/02
A61K 31/535
A61K 31/497
A61K 31/44
US Classification:
546113, 5142345, 51425304, 514300
Abstract:
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.

Fused Ring Heterocycle Kinase Modulators

View page
US Patent:
7626021, Dec 1, 2009
Filed:
Apr 10, 2007
Appl. No.:
11/733753
Inventors:
William D. Arnold - San Diego CA, US
Pierre Bounaud - San Diego CA, US
Chixu Chen - San Diego CA, US
Brian Eastman - San Diego CA, US
Andreas Gosberg - San Marcos CA, US
Stefan N. Gradl - San Diego CA, US
Stephanie Hopkins - Poway CA, US
Zhe Li - San Diego CA, US
Ian McDonald - Killarney Heights, AU
Paul A. Sprengeler - San Diego CA, US
Ruo W. Steensma - La Jolla CA, US
Mark E. Wilson - Ramona CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 471/00
C07D 487/00
US Classification:
544350
Abstract:
The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.

Pyrrolo-Pyridine Kinase Modulators

View page
US Patent:
7709645, May 4, 2010
Filed:
Apr 10, 2007
Appl. No.:
11/733758
Inventors:
William D Arnold - San Diego CA, US
Pierre Bounaud - San Diego CA, US
Chixu Chen - San Diego CA, US
Brian Eastman - San Diego CA, US
Andreas Gosberg - San Marcos CA, US
Stefan N. Gradl - San Diego CA, US
Stephanie Hopkins - Poway CA, US
Zhe Li - San Diego CA, US
Ian McDonald - Killarney Heights, AU
Paul A. Sprengeler - San Diego CA, US
Ruo W. Steensma - La Jolla CA, US
Mark E. Wilson - Ramona CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 471/02
US Classification:
546113
Abstract:
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.

Fused Ring Heterocycle Kinase Modulators

View page
US Patent:
7829558, Nov 9, 2010
Filed:
Sep 22, 2008
Appl. No.:
12/235426
Inventors:
William D. Arnold - San Diego CA, US
Andreas Gosberg - San Diego CA, US
Zhe Li - San Diego CA, US
Ruo W. Steensma - San Diego CA, US
Mark E. Wilson - San Diego CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/5377
A61K 31/437
A61K 31/496
A61P 35/00
US Classification:
5142342, 514303, 51425304
Abstract:
The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.

Pyrrolo-Pyridine Kinase Modulators

View page
US Patent:
7906648, Mar 15, 2011
Filed:
Jul 10, 2009
Appl. No.:
12/501328
Inventors:
William D. Arnold - San Diego CA, US
Pierre Bounaud - San Diego CA, US
Andreas Gosberg - San Diego CA, US
Zhe Li - San Diego CA, US
Ian McDonald - San Diego CA, US
Ruo W. Steensma - San Diego CA, US
Mark E. Wilson - San Diego CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
C07D 471/02
A01N 43/62
US Classification:
546113, 514218
Abstract:
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.

Substituted Pyrrolopyridines And Pyrazolopyridines As Kinase Modulators

View page
US Patent:
8158647, Apr 17, 2012
Filed:
May 29, 2008
Appl. No.:
12/129546
Inventors:
Jeffrey M. Blaney - San Diego CA, US
Andreas Gosberg - San Diego CA, US
Stefan N. Gradl - San Diego CA, US
Gavin Hirst - San Diego CA, US
Stephanie A. Hopkins - San Diego CA, US
Paul A. Sprengeler - San Diego CA, US
Ruo W. Steensma - San Diego CA, US
Johnny Uy - San Diego CA, US
Assignee:
SGX Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/437
A61K 31/5377
A61K 31/497
A61P 35/00
C07D 491/147
C07D 471/04
US Classification:
514300, 546113, 546 64, 546119, 51421018, 514303, 5142345, 51425505, 514187, 544127, 544405
Abstract:
Provided herein are substituted pyrrolopyridine heterocycles and substituted pyrazolopyridine heterocycles, pharmaceutical compositions comprising said heterocycles and methods of using said heterocycles in the treatment of disease. The heterocycles disclosed herein function as kinase modulators and have utility in the treatment of diseases such as cancer, allergy, asthma, inflammation, obstructive airway disease, autoimmune diseases, metabolic disease, infection, CNS disease, brain tumor, obesity, asthma, hematological disorder, degenerative neural disease, cardiovascular disease, or disease associated with angiogenesis, neovascularization, or vasculogenesis.
Andreas Gosberg from Noblesville, IN, age ~53 Get Report